About BioAge Labs
BioAge Labs is a company based in Vallejo (United States) founded in 2015 by Eric Morgen. BioAge Labs has raised $293.9 million across 4 funding rounds from investors including Amgen, Kaiser Permanente and AARP. The company has 64 employees as of December 31, 2024. BioAge Labs offers products and services including NLRP3 Program, APJ Program, and Discovery Platform. BioAge Labs operates in a competitive market with competitors including Helix, Benchling, NantHealth, AskBio and Adocia, among others.
- Headquarter Vallejo, United States
- Employees 64 as on 31 Dec, 2024
- Founders Eric Morgen
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioage Labs, Inc.
-
Annual Revenue
Not available
-
Net Profit
-$71.11 M (USD)-11.36as on Dec 31, 2024
-
EBITDA
-$78.03 M (USD)-61.75as on Dec 31, 2024
-
Total Equity Funding
$293.9 M (USD)
in 4 rounds
-
Latest Funding Round
$170 M (USD), Series D
Feb 13, 2024
-
Investors
Amgen
& 23 more
-
Employee Count
64
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioAge Labs
BioAge Labs is a publicly listed company on the NASDAQ with ticker symbol BIOA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioAge Labs
BioAge Labs offers a comprehensive portfolio of products and services, including NLRP3 Program, APJ Program, and Discovery Platform.
Targets inflammation linked to obesity and metabolic issues
Acts as exercise mimetic for weight loss in obesity
Analyzes multi-omics data for aging and disease mediators
People of BioAge Labs
Unlock access to complete
Unlock access to complete
Funding Insights of BioAge Labs
BioAge Labs has successfully raised a total of $293.9M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $170 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioAge Labs
BioAge Labs has secured backing from 24 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Amgen, Kaiser Permanente and AARP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Locked | Locked | Locked | |
|
Private equity firm focused on life science sector
|
Locked | Locked | Locked | |
|
Life Sciences focused VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for BioAge Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioAge Labs
Investment portfolio details for BioAge Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioAge Labs
Detailed financials for BioAge Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioage Labs Comparisons
Peer comparison for BioAge Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioAge Labs
BioAge Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, NantHealth, AskBio and Adocia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platforms are provided for cancer treatment identification.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
Detailed competitors of BioAge Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioage Labs
Complete news archive for BioAge Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioAge Labs
BioAge Labs was founded in 2015 and raised its 1st funding round 2 years after it was founded.
BioAge Labs is headquartered in Vallejo, United States. It is registered at Vallejo, California, United States.
BioAge Labs is a funded company, having raised a total of $293.9M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at BioAge Labs is 64.
BioAge Labs was founded in 2015 in Vallejo, United States, within the biotechnology sector. A bioinformatics platform is operated to support biomarker identification and drug discovery processes. Computational biology methods are utilized alongside AI technology to analyze genomic data for developing new therapeutic candidates. The companys efforts are centered on enhancing precision in medicine discovery through data-driven approaches.
BioAge Labs's top competitors include Helix, Tonix Pharma and NantHealth.
BioAge Labs offers NLRP3 Program, APJ Program, and Discovery Platform.
Yes, BioAge Labs is publicly traded on NASDAQ under the ticker symbol BIOA.
BioAge Labs has 24 investors. Key investors include Amgen, Kaiser Permanente, AARP, Khosla Ventures, and Orbimed.
The ticker symbol of BioAge Labs is BIOA on NASDAQ.